Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Andersen, CA
Benny Krog Andersen, Ft. Mcmurray CA
| Patent application number | Description | Published |
|---|---|---|
| 20090183837 | Tape dispenser that dispenses overlapping tape and paper structures - A device that dispenses tape structures comprising multiple lengths of overlapping tape. Rolls of tape are attached to the device in a manner that allows the device to unroll lengths of tape into at least one guide and pressing mechanism. In the event that multiple lengths of tape pass through or against the guide and pressing mechanism the lengths of tape overlap and combine into a tape structure comprising multiple lengths of overlapping tape. In a preferred embodiment of the device, the dispensed tape structure comprises adhesive on its opposing surfaces. After creating the tape structure, a blade cuts the tape structure and allows the device to dispense a portion of the tape structure. In addition, the device combines a length of paper with the tape structure by overlapping the length of paper and the tape structure. | 07-23-2009 |
Dave Andersen, Thorsby CA
| Patent application number | Description | Published |
|---|---|---|
| 20110195664 | WIRELESS CONTROL SYSTEM FOR A SPA - A wireless control system is provided for remotely controlling various modules of a spa. The control system comprises a wireless interface for receiving a combination of communication signals containing control data and BLUETOOTH signals from a remote wireless device. The communication signals contain at least control data for controlling the various modules of the spa and the BLUETOOTH signals contain media data such as streaming audio data. The communication signals can be transmitted using Wi-Fi, GSM or CDMA protocols. The control system further comprises a wired interface connected to the various modules of the spa and in communication with the wireless interface. The wired interface controls the various modules of the spa in response to the control data. | 08-11-2011 |
Linda Andersen, Calgary CA
| Patent application number | Description | Published |
|---|---|---|
| 20110178009 | Pheromones and the Luteinizing Hormone for Inducing Proliferation of Neural Stem Cells and Neurogenesis - The present invention provides a method of increasing neural stem cell numbers or neurogenesis by using a pheromone, a luteinizing hormone (LH) and/or a human chorionic gonadotrophin (hCG). The method can be practiced in vivo to obtain more neural stem cells in situ, which can in turn produce more neurons or glial cells to compensate for lost or dysfunctional neural cells. The method can also be practiced in vitro to produce a large number of neural stem cells in culture. The cultured stem cells can be used, for example, for transplantation treatment of patients or animals suffering from or suspected of having neurodegenerative diseases or conditions. | 07-21-2011 |
Raymond Andersen, Vancouver CA
| Patent application number | Description | Published |
|---|---|---|
| 20090088573 | BIOLOGICALLY ACTIVE PEPTIDES AND COMPOSITIONS, THEIR USE - This invention relates to derivatives of hemiasterlin or Geodiamolide G having anti-mitotic activities and useful in treating cancer. These derivatives are represented by general formula I, | 04-02-2009 |
| 20090264487 | HEMIASTERLIN ANALOGS - This invention provides analogs of hemiasterlin, methods of synthesis of the analogs and use of the analogs as a cytotoxic anti-mitotic agents. | 10-22-2009 |
| 20100168225 | Small-Molecule Hepatitis C Virus (HCV) NS3/4A Serine Protease Inhibitors - Compounds of Formula 5 and prodrug compounds of Formula 5 wherein G | 07-01-2010 |
| 20100280004 | SMALL MOLECULE CORRECTORS OF DELTAF508 CFTR TRAFFICKING - This invention provides compounds of Formula I. The compounds are correctors of ΔF508 CFTR trafficking. Also provided are uses of compounds of Formula I for treatment, as well as methods of treatment, of cystic fibrosis. | 11-04-2010 |
| 20100311094 | Allosteric Modulation Of Ship Polypeptides And Uses Thereof - This invention provides a method for identifying allosteric modulators of a SHIP polypeptide, wherein said SHIP polypeptide is contacted with a test compound, and wherein said SHIP polypeptide comprises an allosteric site selected from the group consisting of a SHIP C2 domain and a SHIP PH domain. | 12-09-2010 |
| 20100323990 | SHIP 1 MODULATOR PRODRUGS - The present invention provides the use of prodrugs of pelorol and homopelorol, related compounds and pharmaceutical compositions thereof as modulators of SHIP1 activity. A compound or a pharmaceutical composition of the present invention may be used for the treatment or prophylaxis of an inflammatory, neoplastic, hematopoetic or immune disorder or condition in addition to other disorders and conditions. | 12-23-2010 |
| 20110189107 | ALPHA-AMYLASE INHIBITORS: THE MONTBRETINS AND USES THEREOF - Particular naturally occurring glycosylated acyl-flavonols, e.g. montbretin A (of the formula below wherein R | 08-04-2011 |
Raymond J. Andersen, Vancouver CA
| Patent application number | Description | Published |
|---|---|---|
| 20080255090 | Ceratamines A and B, and Analogues, Syntheses and Pharmaceutical Compositions Thereof - Antimitotic compounds and salts are provided in which the compound has the structure (formula (I)): wherein X and Y are substituted or unsubstituted and are selected from carbon atoms and atoms of groups 15 and 16 of the periodic table; Z is selected from N—R, O and S; U is selected from CR | 10-16-2008 |
| 20090042868 | Indoleamine 2,3-Dioxygenase (IDO) Inhibitors - Inhibitors of indoleamine 2,3-dioxygenase (IDO) are provided as are pharmaceutical compositions containing such inhibitors as well as the use of such inhibitors and compositions for the treatment of a condition in a mammalian subject characterized by pathology of the IDO-mediated tryptophan metabolic pathway. Such conditions may involve suppression of T-cell mediated immune response or may directly result from depletion of tryptophan or accumulation of a product of tryptophan degradation. Specific disease conditions include cataracts, age-related yellowing in the eye, neurodegenerative disorders, mood disorders, cancer and various bacterial/viral infections. IDO inhibitors of this invention are substituted naphthalene and anthracene diones. Novel compounds of this invention include the following taurine-substituted naphthaquinone structure. | 02-12-2009 |
Roger Andersen, Ladysmith CA
| Patent application number | Description | Published |
|---|---|---|
| 20080269205 | METHODS TO PREVENT VERTICAL TRANSMISSION OF INFECTIOUS DISEASES - The present invention presents a method of preventing vertical transmission of an infectious disease comprising: (a) applying a photosensitizing composition to host tissues of birth canal of a mother during the intrapartum period; and (b) applying light to the host tissues after the step (a) at a wavelength absorbed by the photosensitizing composition so as to inhibit or eliminate infectious disease microorganisms that come into contact with the host tissues. The infectious disease may be caused by human immunodeficiency virus type 1, hepatitis B virus, hepatitis C virus, Group B | 10-30-2008 |
| 20090234270 | Therapy and device for treatment of nail infections - The present invention includes a method for treating fungal infections, particularly onychomycosis. The method includes: applying a composition includes a photosensitizer, an effective amount of antifungal agent, and a pharmaceutically acceptable delivery system to a locus and irradiating the locus with a light source at a wavelength absorbed by the photosensitizer so as to destroy microbes at the locus. The present invention also includes a light delivery device for use in photodynamic treatment of onychomycosis comprising (i) a housing adapted to cover a nail beneath which a locus is situated; (ii) a light source; (iii) an energy source in power communication to the light source; and a controller that controls amount of light to be applied to the locus by the light source. | 09-17-2009 |
| 20090317293 | METHOD AND DEVICE FOR ELIMINATING MICROBES WITHIN INDUSTRIAL PIPELINES - The present invention provides a method to inhibit microbes located within a pipeline comprising: applying a photosensitizer composition to a predetermined interior surface area of the pipeline where microbes are located; and applying light to the area at a wavelength that is absorbed by the photosensitizer composition so as to inhibit or eliminate the microbes; wherein the light is applied by a photodynamic disinfection device adapted to provide light to the area. The present invention also provided a photodynamic disinfection device comprising a pipeline inspection gauge (pig) adapted to include a circumferential high energy light source and an energy source wherein the light source is in communication with and powered by the energy source via communication means. | 12-24-2009 |